Journals / Izmir Democracy University Health Sciences Journal / 2019 / Cilt: 2 - Sayı: 3

RECURRENT AMELOBLASTOMA: A CASE REPORT

TEKRARLAYAN AMELOBLASTOMA: BİR OLGU SUNUMU

Pages
177–182
Publication Date
2019-12-29
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

No recurrent was seen during the following period of three years.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Ameloblastoma is a tumor of odontogenic type, arising from the epithelium with fibrous stroma and enamel organ in different steps of evolution.
📊
Key Findings & Data:It arises in the molar-ramus region of mandible with a ratio of 80%.
💡
Conclusion & Impact:No recurrent was seen during the following period of three years.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Ameloblastoma · Marjinal Rezeksiyon · nüks

Abstract

Ameloblastoma is a tumor of odontogenic type, arising from the epithelium with fibrous stroma and enamel organ in different steps of evolution. Ameloblastoma is an odontogenic tumor that is located in the jaw region and though it is a benign entity it may be locally invasive. They are usually diagnosed between the third and fourth decades of life. Mandibula is more affected than maxilla. It arises in the molar-ramus region of mandible with a ratio of 80%. In small lesions enucleation or local resection are the appropriate treatment methods. But larger lesions need marginal resection. It has a high ratio of recurrence. In our case we report a recurrent ameloblastoma is presented. The patien was operated in a different of medicine with the diagnosis of ameloblastoma.We applied marginal resection. No recurrent was seen during the following period of three years.

Özet

Ameloblastoma çeşitli gelişim aşamalarındaki enamel organ ve fibröz stromalı epitelden gelişen odontojenik bir neoplazidir. Ameloblastoma, çene bölgesinde görülen, iyi huylu olmasına karşılık lokal yayılım gösteren bir tümördür. Genellikle hayatın üçüncü veya dördüncü dekatında daha sık teşhis edilirler. Mandibula maksilladan daha sık etkilenir. %80 oranında mandibular molar-ramus bölgesinde ortaya çıkar. Küçük lezyonlarda genellikle enükleasyon veya rezeksiyon yeterlidir. Fakat büyük lezyonlarda marjinal rezeksiyon gereklidir. Rekürrensi yüksektir. Sunulan bu olguda başka bir merkezde daha önce opere edilen ameloblastoma vakası sunulmuştur. Marjinal rezeksiyon yaptığımız vaka da üç yıllık takipte nüks görülmemiştir

🔖

Cite This Article

ERDOĞMUŞ, Z., KOPARAL, M. (2019). RECURRENT AMELOBLASTOMA: A CASE REPORT. Izmir Democracy University Health Sciences Journal, Cilt: 2 - Sayı: 3, 177–182. https://ajindex.com/articles/769980

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Almeida R. A. C., Andrade E. S. S., Barbalho J. C., Vajgel A., Vasconcelos B. C. E. (2016). Recurrence rate following treatment for primary multicystic ameloblastoma: systematic review and meta-analysis,” International Journal of Oral and Maxillofacial Surgery, 45(3), 359–367.
  2. Angadi P.V. (2011). Head and neck: odontogenic tumor: ameloblastoma. Atlas of Genetics and Cytogenetics in Oncology and Haematology, 15, 223–229.
  3. B. Ahlema, A., Wideda, L., Amanib Z., Nadiaa A., Amiraa and. Fatena F.(2015). Study of Ki67 and CD10 expression as predictive factors of recurrence of ameloblastoma. European Annals of Otorhinolaryngology, Head and Neck diseases, 132(5), 275–279.
  4. Becelli R., Carboni A., Cerulli G., Perugini M., Lannetti G. (2002). Mandibular ameloblastoma: analysis of surgical treatment carried out in 60 patients between 1977 and 1998. Journal of Craniofacial Surgery, 13(3), 395-400.
  5. Becelli R., Morello R., Renzi G., Matarazzo G., Dominici C.(2011). Treatment of recurrent mandibular ameloblastoma with segmental resection and revascularized fibula free flap. Journal of Craniofacial Surgery, 22, 1163–1165.
  6. Belli E, Rendine G, Mazzone N.(2009) Ameloblastoma relapse after 50 years from resection treatment. J Craniofac Surgery, 20,1146–1149.
  7. Chaine A., Pitak-Arnnop P., Dhanuthai K., Ruhin-Poncet B., Bertrand JC., Bertolus C. (2009). A treatment algorithm for managing giant mandibular ameloblastoma: 5-year experiences in a Paris University Hospital. European Journal of Surgical Oncology, 35, 999–1005.
  8. Cihangiroğlu M., Akfırat M., Yıldırım H.(2002).CT and MRI findings of ameloblastoma in two cases. Neuroradiology, 44, 434-437.
  9. Damjanov I, Linder J. (1996). Anderson's Pathology( 10th ed.). St. Louis: MosbyYear Book,1603. El-Naggar, Chan JKC, Grandis JR, Takata T, Slootweg P, editors(2017). WHO classification of Head and Neck Tumours (chapter 8). Odontogenic and maxilofacial bone tumours. 4th ed., IARC: Lyon, 205-260.
  10. Escande C., Chaine A., Menard P.(2009). A treatment algorithm for adult ameloblastomas according to the Pitié-Salpêtrière Hospital experience. Journal Craniomaxillofacial of Surgery, 37, 363–369. Fregnani ER., da Cruz Perez DE., de Almeida OP., Kowalski LP., Soares FA., de Abreu Alves F.(2010). Clinicopathological study and treatment outcomes of 121 cases of ameloblastomas. International Journal Oral Maxillofacial Surgery, 39, 145–149.
  11. Hong J., Yun PY., Chung IH. (2007). Long-term follow up on recurrence of 305 ameloblastoma cases. International Journa